KEY GENE VALIDATION IN HEPATIC FIBROSIS AND HEPATOCELLULAR CARCINOMA IN AFRICAN AMERICANS WITH NAFLD

被引：0

作者：

Mondal, Tanmoy ^{[1
]}

Smith, Coleman I. ^{[2
]}

Loffredo, Christopher A. ^{[3
]}

Quartey, Ruth ^{[1
]}

Howell, Charles D. ^{[4
]}

Korba, Brent E. ^{[3
]}

Bernard, Kwabi-Addo ^{[1
]}

Nunlee-Bland, Gail ^{[1
]}

Rucker, Leanna ^{[2
]}

Moses, Gemeyel ^{[1
]}

Clark, Marika ^{[1
]}

Cotin, Sharleine ^{[1
]}

Johnson, Jheannelle ^{[1
]}

Newheart, Miranda ^{[1
]}

Bentley, Faith ^{[1
]}

Pope, Tia ^{[1
]}

Lightsey, Nacorria ^{[1
]}

Davis, Triniti ^{[1
]}

Oyebola, Oluwaseyi ^{[1
]}

Matthews, Karma A. ^{[1
]}

Sahota, Jasneet ^{[1
]}

Ghosh, Somiranjan ^{[1
]}

机构：

[1] Howard Univ, Washington, DC 20059 USA

[2] Georgetown Univ Hosp, Washington, DC 20007 USA

[3] Georgetown Univ, Washington, DC 20057 USA

[4] Howard Univ Hosp, Washington, DC USA

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2062A

引用

页码：S818 / S819

页数：2

共 50 条

[31] Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach
Fei, Xiaobin
Liu, Songbai
Liu, Peng
Wang, Xing
Zhu, Changhao
Hou, Junyi
Cai, Junzhe
Pan, Yaozhen
FRONTIERS IN ONCOLOGY, 2022, 12
[32] Leveraging drug perturbation to reveal genetic regulators of hepatic gene expression in African Americans
Zhong, Yizhen
De, Tanima
Mishra, Mrinal
Avitia, Juan
Alarcon, Cristina
Perera, Minoli A.
AMERICAN JOURNAL OF HUMAN GENETICS, 2023, 110 (01) : 58 - 70
[33] Features of hepatocellular carcinoma in Hispanics differ from African Americans and non-Hispanic Whites
Neeta K Venepalli
Mary V Modayil
Stephanie A Berg
Tad D Nair
Mayur Parepally
Priyanka Rajaram
Ron C Gaba
James T Bui
Yue Huang
Scott J Cotler
World Journal of Hepatology, 2017, (07) : 391 - 400
[34] HEPATOCYTE HIF-1 MEDIATES GENE EXPRESSION CHANGES AFFECTING HEPATIC FIBROSIS IN MURINE NAFLD
Mesarwi, O. A.
Shin, M.
Bevans-Fonti, S.
Moya, E.
Polotsky, V. Y.
Xu, G.
Fisch, K.
Malhotra, A.
SLEEP, 2018, 41 : A10 - A11
[35] Models to Predict Development or Recurence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Hepatic Fibrosis
Yilma M.
Saxena V.
Mehta N.
Current Gastroenterology Reports, 2022, 24 (1) : 1 - 9
[36] Hepatic siderosis, fibrosis and cirrhosis: The association with hepatocellular carcinoma in high-risk population
Jaskiewicz, K
Banach, L
Lancaster, E
ANTICANCER RESEARCH, 1997, 17 (5B) : 3897 - 3899
[37] STATIN USE AND HEPATOCELLULAR CARCINOMA IN PARTICIPANTS WITH HEPATIC FIBROSIS IN THE ALL OF US RESEARCH PROGRAM
Almazan, Erik
Chung, Raymond
HEPATOLOGY, 2024, 80
[38] INDEPENDENT GENETIC DETERMINANTS OF HEPATIC FIBROSIS AND HEPATOCELLULAR CARCINOMA IN A MURINE GENETIC REFERENCE POPULATION
Weber, Susanne N.
Hall, Rabea A.
Lammert, Frank
HEPATOLOGY, 2008, 48 (04) : 353A - 353A
[39] Multiple drugsHepatitis B reactivation, hepatic fibrosis and hepatocellular carcinoma: 3 case reports
Reactions Weekly, 2018, 1709 (1) : 165 - 165
[40] Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine
Ding, Yong-fang
Wu, Zhen-hui
Wei, Ying-jie
Shu, Luan
Peng, Yun-ru
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (05) : 821 - 834

← 1 2 3 4 5 →